Search Results - immunotherapy.+restifo

1 Results

Sort By:

Methods of Producing T-cell Populations Using P38 MAPK Inhibitors

Abstract: Adoptive cell therapy (ACT) uses cancer reactive T-cells to effectively treat patients. However, several obstacles inhibit the successful use of ACT for cancer treatment. Current approaches for the expansion of T-cells may produce T-cells with a terminally differentiated phenotype that is associated with diminished anti-tumor activity and...

Published: 4/8/2024 | Inventor(s): Nicholas Restifo, Shashankkumar Patel

Keywords(s): Immunotherapy. Restifo, inhibitor, Mapk, P38, T-CELLS

Category(s): Application > Therapeutics, Collaboration Sought > Licensing, TherapeuticArea > Oncology